POTASSIUM TETRACYANONICKELATE(II) HYDRATE

Suppliers

Names

[ CAS No. ]:
14323-41-2

[ Name ]:
POTASSIUM TETRACYANONICKELATE(II) HYDRATE

[Synonym ]:
Dipotassium tetracyanonickelate hydrate
Tetracyanonickelate(2-) dipotassium hydrate
UNII-TR11HQD73G
Potassium tetracyanonickelate(ii) hydrate [MI]
Potassium cyanonickelate hydrate
Nickelate(2-),tetracyano-,dipotassium,hydrate
dipotassium nickel(2+) tetracyanide hydrate

Chemical & Physical Properties

[ Boiling Point ]:
25.7ºC at 760mmHg

[ Molecular Formula ]:
C4H2K2N4NiO

[ Molecular Weight ]:
258.97500

[ Exact Mass ]:
257.88600

[ PSA ]:
104.39000

[ LogP ]:
0.00282

[ Vapour Pressure ]:
740mmHg at 25°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QR6127000
CHEMICAL NAME :
Nickelate(2-), tetracyano-, dipotassium, hydrate
CAS REGISTRY NUMBER :
14323-41-2
LAST UPDATED :
199701
DATA ITEMS CITED :
26
MOLECULAR FORMULA :
C4-N4-Ni.K.H2-O
MOLECULAR WEIGHT :
219.91
WISWESSER LINE NOTATION :
.KA..NI-CN4 QH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

TYPE OF TEST :
Cytogenetic analysis
TEST SYSTEM :
Rodent - mouse Mammary gland
DOSE/DURATION :
1600 umol/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 68,337,1979 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 1 mg(Ni)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,178,1971 OSHA PEL (Gen Indu):8H TWA 1 mg(Ni)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 1 mg(Ni)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 1 mg(Ni)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 1 mg(Ni)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-ARAB Republic of Egypt:TWA 0.1 mg(Ni)/m3 JAN 1993 OEL-AUSTRALIA:TWA 1 mg(Ni)/m3 JAN 1993 OEL-BELGIUM:TWA 1 mg(Ni)/m3 (insoluble compounds) JAN 1993 OEL-DENMARK:TWA 0.05 mg(Ni)/m3;Carcinogen JAN 1993 OEL-DENMARK:TWA 1 mg(Ni)/m3 (insoluble compounds) JAN 1993 OEL-FINLAND:TWA 0.1 mg(Ni)/m3;Skin;Carcinogen (insoluble compounds) JAN 1993 OEL-FRANCE:TWA 1 mg(Ni)/m3 JAN 1993 OEL-GERMANY;Carcinogen JAN 1993 OEL-HUNGARY:STEL 0.005 mg(Ni)/m3;Carcinogen (insoluble compounds) JAN 1993 OEL-JAPAN:TWA 1 mg(Ni)/m3;Carcinogen JAN 1993 OEL-THE NETHERLANDS:TWA 0.1 mg(Ni)/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 1 mg(Ni)/m3 (insoluble compounds) JAN 1993 OEL-THE PHILIPPINES:TWA 1 mg(Ni)/m3 JAN 1993 OEL-RUSSIA:STEL 0.05 mg(Ni)/m3 JAN 1993 OEL-SWEDEN:TWA 0.5 mg(Ni)/m3 JAN 1993 OEL-SWITZERLAND:TWA 0.5 mg(Ni)/m3 (insoluble compounds) JAN 1993 OEL-SWITZERLAND:TWA 0.5 mg(Ni)/m3;Carcinogen JAN 1993 OEL-THAILAND:TWA 1 mg(Ni)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 0.5 mg(Ni)/m3 (insoluble compounds) JAN 1993 OEL-UNITED KINGDOM:TWA 1 mg(Ni)/mg;STEL 3 mg(Ni)/m3 JAN 1993

Safety Information

[ Hazard Codes ]:
T: Toxic;

[ Risk Phrases ]:
R49

[ Safety Phrases ]:
S53

[ RIDADR ]:
UN 1588 6.1/PG 2


Related Compounds

  • Potassium tetracyanonickelate(II) hydrate
  • potassium hexacyanoruthenate(ii) hydrate
  • POTASSIUM HEXACYANORUTHENATE(II) HYDRATE
  • SODIUM TETRACHLOROPLATINATE(II) HYDRATE
  • lithium tetrachloropalladate(ii) hydrate
  • SODIUM TETRACYANOPLATINATE(II) HYDRATE
  • 2-[5-cyclobutyl-1-(2-methoxyethyl)-1H-1,2,3-triazol-4-yl]acetonitrile
  • 4-(6-Chloropyridin-2-yl)butan-1-amine
  • 6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid 2-[(2-hydroxy-4-methoxyphenyl)methylene]hydrazide
  • Carbamic acid, [3-[(2-bromo-5-ethoxyphenyl)amino]-1-methyl-3-oxopropyl]-, 1,1-dimethylethyl ester
  • 3-(3,4-Dimethoxyphenyl)-1-[hexahydro-4-(5-nitro-2-pyridinyl)-1H-1,4-diazepin-1-yl]-2-propen-1-one
  • 4H-1-Benzopyran-4-one, 5,7-bis(acetyloxy)-2-[4-(acetyloxy)phenyl]-2,3-dihydro-6,8-dimethyl-, (S)-
  • 4H-1-Benzopyran-4-one, 7-[(6-deoxy-I+/--L-mannopyranosyl)oxy]-2,3-dihydro-2-(4-methoxyphenyl)-, (S)-
  • rel-Ethyl (4aR,9bS)-1,3,4,4a,5,9b-hexahydro-5-(phenylmethyl)-2H-pyrido[4,3-b]indole-2-carboxylate
  • 1,2,3,4,5,6-Hexahydro-3-(2-hydroxy-1-methylethyl)-1,5-methano-8H-pyrido[1,2-a][1,5]diazocin-8-one
  • 5-[2-(Diethylamino)ethyl]-1,5-dihydro-1-methyl-6-(phenylmethyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.